PharmaSGP Holding SE (PSG.DE)

EUR 24.8

(4.2%)

Annual Income Statements

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 101.09 Million 85.82 Million 65.34 Million 63.24 Million 62.57 Million 60.59 Million
Cost of Revenue 9.46 Million 9.03 Million 6.48 Million 6.2 Million 5.86 Million 10.3 Million
Gross Profit 91.63 Million 76.79 Million 58.85 Million 57.04 Million 56.7 Million 50.29 Million
Operating Expenses 50.72 Million 59.1 Million 43.36 Million 40.96 Million 32.22 Million 30.94 Million
Selling, General and Administrative Expenses 43.38 Million 37.37 Million 31.78 Million 34.59 Million 28.12 Million 30.94 Million
Research and Development Expenses - - - - - -
Other Expenses - 386 Thousand - - - -
Cost and Expenses 60.18 Million 68.14 Million 49.85 Million 47.17 Million 38.09 Million 41.25 Million
Operating Income 40.91 Million 17.59 Million 15.42 Million 16.04 Million 24.4 Million 19.34 Million
Interest Expense 4.41 Million 2 Million 643 Thousand 75 Thousand 75 Thousand -
Income Tax Expense 5.49 Million 3.84 Million 3.51 Million 3.5 Million 5.55 Million 4.8 Million
Earnings before Tax 21.89 Million 15.8 Million 14.2 Million 14.14 Million 22.26 Million 19.53 Million
Net Income 16.39 Million 11.95 Million 10.69 Million 10.64 Million 16.7 Million 14.73 Million
Earnings Per Share Basic 1.37 1.00 0.89 0.89 1.39 1.23
Earnings Per Share Diluted 1.37 1.00 0.89 0.89 1.39 1.23
Weighted Average Shares Outstanding 11.99 Million 12 Million 12 Million 12 Million 12 Million 12 Million
Weighted Average Shares Outstanding (Diluted) 11.99 Million 12 Million 12 Million 12 Million 12 Million 12 Million
Gross Margin 0.91 0.89 0.90 0.90 0.91 0.83
EBIT Margin 0.35 0.31 0.29 0.26 0.40 0.33
Profit Margin 0.16 0.14 0.16 0.17 0.27 0.24
EBITDA 35.86 Million 27.17 Million 18.49 Million 14.73 Million 22.83 Million 19.93 Million
Earnings Before Tax Margin 0.40 0.21 0.24 0.25 0.39 0.32

Income Statement Charts